IRA INFORM REPORT

 

 

Report No. :

324690

Report Date :

01.06.2015

 

IDENTIFICATION DETAILS

 

Name :

CADILA PHARMACEUTICALS LIMITED

 

 

Registered Office :

Cadila Corporate Campus, Sarkhej Dhokla Road, Ahmedabad – 380008, Gujarat

Tel. No.:

91-2718-225001

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

28.02.1991

 

 

Com. Reg. No.:

015132

 

 

Capital Investment / Paid-up Capital :

Rs.845.739 Million

 

 

CIN No.:

[Company Identification No.]

U24231GJ1991PLC015132

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACC6251E

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer, Exporter and Importer of Pharmaceuticals Products.

 

 

No. of Employees :

Information denied by management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (54)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having good track.

 

The rating reflects company sound financial risk profile marked by healthy networth and decent profitability of the company.

 

The rating also takes into consideration company long standing track record and its experienced management in pharmaceutical industry.

 

Trade relations are reported as fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term bank facilities : A

Rating Explanation

Adequate degree of safety and carry low credit risk.

Date

12.02.2015

 

Rating Agency Name

CARE

Rating

Short term bank facilities : A1

Rating Explanation

Very strong degree of safety and carry lowest credit risk.

Date

12.02.2015

 

 

RBI DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DECLINED

 

Management non co-operative

 

Contact No.: 91-2718-225001

 

LOCATIONS

 

Registered/ Corporate Office :

Cadila Corporate Campus, Sarkhej Dhokla Road, Ahmedabad – 380008, Gujarat, India

Tel. No.:

91-2718-225001 (15 Lines)

Fax No.:

91-2718-225039

E-Mail :

secretarial@cadilapharma.co.in 

website@cadilapharma.co.in

accounts@cadilapharma.co.in 

rmankodi@cadilapharma.co.in

purchase@cadilapharma.com

branded@cadilapharma.com

rnair@cadilapharma.co.in

shreyas.parikh@cadilapharma.co.in

Website :

http://www.cadilapharma.com

Location :

Owned

Factory 1 :

Dholka – Manufacturing Plant

Survey No. 1389, Trasad Road, Dholka, Ahmedabad – 387810, Gujarat, India

Tel. No:

91-79-23421841 / 83 / 84 / 23422006 / 7 / 8 / 9 / 10

Fax No:

91-79-23420315

 

 

Factory 2 :

Chemical SBU

294, GIDC Estate, Ankleshwar, Gujarat, India

Tel. No:

91-2646-223846/ 252626/ 251519 

Fax No:

91-2646-250051

 

 

Factory 3 :

CHPL – Factory / Karnavati Engineering Limited

Survey No. 342, Nani Kadi, Taluka Kadi, District Mehsana,   North Gujarat, India

Tel. No:

91-2764-262463/ 242037/ 242194/ 241464-65

Fax No:

91-2764-242223/ 242608

 

 

Factory 4 :

Chemicals SBU

Factory Plot No. 274, GIDC Industrial Estate, Ankleshwar, Gujarat, India

Tel. No:

91-2646-223846/ 252626/ 251519

Fax No:

91-2646-250051

 

 

Factory 5 :

Tissu Culture Lab

756, Prakruti Farm, Hirapur Chowkdi, Hirapur, Ahmedabad, Gujarat, India

Tel. No:

91-79-3855260/ 3855495/ 496

 

 

Factory 6 :

Cadila Pharmaceuticals Limited, Jammu

Industrial Growth Centre, Samba – 184121, District Jammu, Jammu and Kashmir, India

Tel. No:

91-1923-241113/ 241114/ 241115

Fax No:

91-1923-246744

 

 

DIRECTORS

 

As on 24.09.2014

 

Name :

Dr. Rajiv Indravadan Modi

Designation :

Managing director

Address :

13, Sanjiv Building, New Sharda Mandir Road, Paldi,  Ahmedabad – 380007, Gujarat, India

Date of Birth/Age :

09.05.1960

Qualification :

Ph. D (Biological Science), M. Sc (Biochemical Engineering), B. Tech(Chemical Engineering)

Date of Appointment :

01.07.2010

PAN No.:

AAPPM9265J

DIN No.:

01394558

 

 

Name :

Mrs. Shilaben Indravadan Modi

Designation :

Director

Address :

13, Sanjiv Baug, New Sharda Mandir Road, Ahmedabad – 380007, Gujarat, India

Date of Birth/Age :

09.12.1931

Qualification :

Matriculate

Date of Appointment :

16.12.1995

PAN No.:

AEYPM8647R

DIN No.:

01976356

 

 

Name :

Mrs. Monika Garware Modi

Designation :

Director

Address :

13, Sanjiv Building, New Sharda Mandir Road, Paldi,  Ahmedabad – 380007, Gujarat, India

Date of Birth/Age :

04.06.1963

Qualification :

M.B.A. from Pace University, New York, USA

Date of Appointment :

15.12.1995

PAN No.:

AEQPG3834C

DIN No.:

00143400

 

 

Name :

Mr. Chinubhai Ramanlal Shah

Designation :

Director

Address :

402, Heritage Cresent, Behind Prahladnagar Garden, Near Jain Derasar, S. G. Highway, Ahmedabad – 380051, Gujarat, India

Date of Birth/Age :

04.06.1937

Qualification :

M.A., L.L.M. (Gold Medalist), DLP, DTP, FCS, Life Fellow AIMA

Date of Appointment :

31.03.2001

DIN No.:

00558310

 

 

Name :

Mr. Pradip Navin Khandwalla

Designation :

Director

Address :

B/101, Jupiter Tower, Opposite Samkit Bunglows, Bodakdev, Ahmedabad – 380054, Gujarat, India

Date of Birth/Age :

18.02.1940

Qualification :

B. Com. (Com), MBA (Wharton, Penn.), Ph.D. (Carnegie-Mellon), ACA

Date of Appointment :

14.09.2007

DIN No.:

00064643

 

 

Name :

Mr. Daya Nand Khurana

Designation :

Director

Address :

288, Vasant Enclave, Vasant Vihar, New Delhi - 110057, India

Date of Birth/Age :

15.05.1935

Qualification :

B.E.(EC)

Date of Appointment :

04.07.2003

DIN No.:

00020601

 

 

Name :

Mr. Atul Bipinbhai Tandon

Designation :

Director

Address :

A/43, Royal Orchid, Corporate Road, Opposite Prahlad Nagar Gardens, Prahlad Nagar, Ahmedabad – 380015, Gujarat, India

Date of Birth/Age :

03.01.1948

Qualification :

B. Tech from I.I.T, Bombay and PGDBA from IIM, Ahmedabad

Date of Appointment :

04.07.2003

Date of Cessation :

01.03.2015

DIN No.:

00165667

 

 

Name :

Mr. Narendra Jamnadas Jhaveri

Designation :

Director

Address :

C-42, Samprat Residency, Premchandnagar, Bodakdev, Ahmedabad – 380015, Gujarat, India

Date of Birth/Age :

09.08.1935

Date of Appointment :

07.05.2013

Date of Cessation :

10.02.2015

DIN No.:

00198912

 

 

KEY EXECUTIVES

 

Name :

Amitabha Banerjee

Designation :

CFO

Address :

A-902, Prestige Tower, Off. Judges Bunglow Road,, Vastrapur, Ahmedabad - 380015, Gujarat, India

PAN No.:

AADPB0669D

Date of Appointment :

08.07.2014

 

 

Name :

Srinivas Kotra

Designation :

Secretary

Address :

M-101, Venus Parkland,, Vejalpur Road,, Ahmedabad - 380051, Gujarat, India

PAN No.:

AEVPK6767P

Date of Appointment :

23.03.2015

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 24.09.2014

 

Names of Shareholders [Equity Shares]

 

No. of Shares

R. I. Modi (Karta of I.A. Modi HUF)

 

10

R. I. Modi (Trustee of IRM Trust)

 

79999976

R. I. Modi (Trustee of Mansi Trust)

 

10

IRM Limited, India

 

1

Karnavati Engineering Limited, India

 

1

Green Channel Logi Solutions Limited, India

 

1

Minikaben Modi

 

1

Total

 

80000000

 

 

As on 24.09.2014

 

Names of Shareholders [Preference Shares]

 

No. of Shares

R. I. Modi (Indusrialist)

 

44346

Minikaben Modi (Trustee of IRM Trust)

 

4465088

CPL Infrastructure Private Limited, India

 

49462

IRM Limited, India

 

5000

Karnavati Engineering Limited, India

 

5000

Inverika Bioresearch Private Limited, India

 

5000

 

 

 

Total

 

4573896

 

 

As on 24.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Bodies corporate

100.00

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Exporter and Importer of Pharmaceuticals Products.

 

 

Products :

Product Description

Item Code No. (ITC Code)

Ethambutol

29051410

Ranitidine

29420014

Sulphameth Axazole

29350011

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

PRODUCTION STATUS : NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Maximum Limit Dealt :

Not Available

Experience :

Not Available

Remark:

Not Available

 

 

Customers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Maximum Limit Dealt :

Not Available

Experience :

Not Available

Remark:

Not Available

 

 

No. of Employees :

Information denied by management

 

 

Bankers :
  • Union Bank of India, IFB, C. U. Shah Chambers, Ashram Road, Ahmedabad - 380014, Gujarat, India
  • Bank of Baroda, Corporate Financial Services Branch, 1st Floor, BOB Towers, Opposite Law Garden, Ellisbrdige, Ahmedabad - 380009, Gujarat, India
  • Export-Import Bank of India, Centre One Building, Floor 21, World Trade Centre Complex; Cuffe Parade, Mumbai - 400005, Maharashtra, India
  • Indian Overseas Bank, 401, 403 Sigma Legacy, Near Polytechnic Cross Road, IIRM Road, Ahmedabad - 380015, Gujarat, India
  • Bank of India
  • Corporation Bank
  • ICICI Bank Limited
  • Vijaya Bank
  • HDFC Bank Limited
  • Canara Bank
  • Syndicate Bank
  • Dena Bank
  • Central Bank of India

 

 

Facilities :

SECURED LOANS

31.03.2014

Rs. In Million

31.03.2013

Rs. In Million

LONG TERM BORROWINGS

 

 

Rupee term loans from banks

2636.999

2409.028

Other loans and advances

69.043

80.643

SHORT TERM BORROWINGS

 

 

Working capital loans from banks

1600.558

1651.617

Buyer’s Credit

0.000

5.726

Total

4306.600

4147.014

 

NOTE : 

 

Secured by the hypothecation of stock in trade, packing materials, stores and spare parts , book-debts and further secured by second charge on all movable and building situated at Jammu and vehicles in note 5(A) (c)

 

Buyer's credit of Rs. Nil (Previous year Rs. 5.726 Million) is secured by the hypothecation of stock in trade, packing materials, stores and spare parts , book-debts immovable fixed assets of the Company except land and building situated at Jammu and vehicles in note 5 (A) (c)

 

There are no defaults in repayment of loan and interest thereon as on March 31, 2014.

 

A Securities for Term Loans :

 

[a] Term loans of Rs. 2661.999 Million (includes Rs.408.500 Million as per Note 10) from Banks secured by first pari passu charge on all movable and immovable fixed as mentioned at [c] below, by way of Equitable Mortgage on land and building and hypothecation of plant and machinery (both present and future).

 

[b] Term loans of Rs. 404.500 Million (includes Rs.21.000 Million) from Banks secured by second pari passu charge on all movable and immovable fixed assets of the Company.

 

[c] below, by way of Equitable Mortgage on land and building and hypothecation of plant and machinery (both present and future).

 

[c] Vehicle loan of Rs.128.303 Million (includes Rs.59.259. Million) is secured by hypothecation of specific vehicles financed out of the loans.

B Terms of repayment :

 

[a] Term Loan from Bank of Baroda Rs.121.875 Million carries interest @ BR+2 % p.a. and repayble in 20 quarterly installments after moratorium of 2 years.

 

[b] Term Loan from Bank of Baroda of Rs.312.000 Million carries interest @ BR+ 2% p.a. and repayable in 20 quarterly installments after moratorium of 2 years.

 

[c] Term Loan from Bank of Baroda of Rs.528.125 Million carries interest @ BR+ 2% p.a. and repayable in 16 quarterly installments after moratorium of 2 years.

 

[d] Term Loan from Bank of Baroda of Rs.1250.000 Million carries interest @ BR+ 0.25% p.a. and repayable in 24 quarterly installments after moratorium of 2 years.

 

[e] Term Loan from EXIM Bank of Rs.404.500 Million carries interest @ LTMLR+2.30% p.a. and repayable in 20 quarterly installments after moratorium of 2 years

 

[f] Term Loan from Indian Overseas Bank of Rs.400.000 Million carries interest @ BR+1.25% p.a. and repayable in 20 quarterly installments after moratorium of 2 years.

 

[g] Term Loan from Union Bank of India of Rs.50.000 Million carries interest @ BR+2% p.a. and repayable in 20 quarterly installments after moratorium of 2 years.

 

The amounts shown above from B[a] to B[g] includes current portion of loans

 

Vehicle loan carries interest @ 7.84 % to 12.35 % and repayable in 36 months to 60 months installments.

 

Deposits accepted for the period 1 year to 3 years and carries interest @ 1% & 7.50% p.a.

 

Auditors :

 

Name :

Deloitte Haskins and Sells

Chartered Accountants

Address :

Heritage', 3rd Floor, Near Gujarat Vidypith, Off. Ashram Road, Ahmedabad – 380014, Gujarat, India

PAN No.:

AABFD7919A

 

 

Memberships :

 

 

 

Collaborators :

 

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives:
  • A.J. Modi Family Trust
  • CPL Infrastructure Private Limited U67120GJ1995PTC025713
  • Dr. Rajiv Modi -HUF
  • I.A. Modi Family Trust
  • I.A. Modi (H.U.F
  • IRM Enterprises Private Limited U74999GJ2009PTC058116
  • IRM Limited
  • IRM Trust
  • Indraj Trust
  • Inverika Bioresearch Private Limited U73100GJ2012PTC070636
  • Karnavati Engineering Limited
  • Manendra Family Trust
  • Mansi Family Trust
  • Manthan Family Trust
  • Mayur Family Trust
  • Mihir Family Trust
  • Miten Family Trust
  • Omni Care Pharmaceuticals Limited
  • Raj Trust
  • Rajiv Family Trust
  • Shantaben Family Will Trust
  • Shilaben Family Trust
  • Shilraj trust
  • A J Modi HUF

 

 

Joint venture :
  • Apollo Hospitals International Limited U85110TN1997PLC039016
  • Casil BG Medical Devices

 

 

Associate :
  • Casil Health Products Limited U51909GJ1995PLC027839
  • Casil Industries Limited U24231GJ2000PLC038320
  • Green Channel Logi-Solutions Limited U63023GJ2008PLC052813

 

 

Subsidiary company :
  • CPL Biologicals Private Limited U01403GJ2009PTC056409
  • C P L INC.
  • CPL Agro Products Private Limited U01403GJ2009PTC056669
  • Cadila Pharmaceuticals (Ethiopia) Private Limited
  • CPL Holdings Private Limited U65993GJ2009PTC056511
  • Cadila Pharmaceuticals (E.A) Limited
  • Interpharma Ind Limited
  • Kadera Yakuhin Limited
  • Satellite Overseas Holdings Limited (SOHL)

 

 

CAPITAL STRUCTURE

 

AS ON 24.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

80,000,000

Equity Shares

Rs.10/- each

Rs.800.000 Million

4,600,000

Preference Shares

Rs.10/- each

Rs.46.000 Million

 

Total

 

Rs.846.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

80,000,000

Equity Shares

Rs.10/- each

Rs.800.000 Million

4,573,896

Preference Shares

Rs.10/- each

Rs.45.739 Million

 

Total

 

Rs.845.739 Million

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

845.739

800.000

800.000

(b) Reserves & Surplus

2412.115

2649.738

1519.643

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

45.739

0.000

Total Shareholders’ Funds (1) + (2)

3257.854

3495.477

2319.643

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

3415.149

3355.522

3562.681

(b) Deferred tax liabilities (Net)

529.632

533.130

506.056

(c) Other long term liabilities

260.128

238.196

216.247

(d) long-term provisions

39.443

34.082

22.199

Total Non-current Liabilities (3)

4244.352

4160.930

4307.183

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1600.558

1657.343

1456.278

(b) Trade payables

1990.376

1898.366

1510.784

(c) Other current liabilities

964.353

1569.046

1330.906

(d) Short-term provisions

253.511

161.642

82.386

Total Current Liabilities (4)

4808.798

5286.397

4380.354

 

 

 

 

TOTAL

12311.004

12942.804

11007.180

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

5050.742

4936.297

3452.190

(ii) Intangible Assets

17.719

24.766

20.862

(iii) Capital work-in-progress

698.521

653.876

467.041

(iv) Intangible assets under development

0.000

79.850

50.104

(b) Non-current Investments

659.726

1495.097

1308.584

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

1015.837

969.511

1043.679

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

7442.545

8159.397

6342.460

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

1643.251

1563.096

1535.482

(c) Trade receivables

2195.103

2176.671

2299.033

(d) Cash and cash equivalents

384.599

335.504

170.057

(e) Short-term loans and advances

614.195

644.456

559.008

(f) Other current assets

31.311

63.680

101.140

Total Current Assets

4868.459

4783.407

4664.720

 

 

 

 

TOTAL

12311.004

12942.804

11007.180

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from operations

12522.565

10847.912

9180.545

 

 

Other Income

211.769

120.054

115.540

 

 

TOTAL                                    

12734.334

10967.966

9296.085

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

3591.936

3381.237

3127.037

 

 

Purchases of Stock-in-Trade

1199.359

883.621

650.190

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(53.159)

27.206

(14.338)

 

 

Employees benefits expense

2200.438

1921.180

1491.765

 

 

Other expenses

3957.474

3042.351

2574.240

 

 

Exceptional Items

0.000

452.480

404.260

 

 

TOTAL                                    

10896.048

9708.075

8233.154

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

1838.286

1259.891

1062.931

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

553.461

643.567

609.876

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

1284.825

616.324

453.055

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

281.200

269.546

255.268

 

 

 

 

 

 

PROFIT BEFORE TAX

1003.625

346.778

197.787

 

 

 

 

 

Less

TAX                                                     

24.203

46.324

55.932

 

 

 

 

 

 

PROFIT AFTER TAX

979.422

300.454

141.855

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

4665.156

3795.450

2927.473

 

 

Other Earnings

35.520

20.712

12.042

 

TOTAL EARNINGS

4700.676

3816.162

2939.515

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

585.886

454.231

242.276

 

 

Stores & Spares

21.056

8.001

9.302

 

 

Capital Goods

16.253

73.167

84.684

 

TOTAL IMPORTS

623.195

535.399

336.262

 

 

 

 

 

 

Earnings Per Share (Rs.)

12.24

3.76

1.77

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

513.522

990.430

856.910

Cash generated from operations

 

 

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin
(PAT / Sales)

(%)

7.82

2.77

1.55

 

 

 

 

 

Operating Profit Margin
(PBIDT/Sales)

(%)

14.68

11.61

11.58

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

9.16

3.24

2.15

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.31

0.10

0.09

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.70

1.72

2.53

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.01

0.90

1.06

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

800.000

800.000

845.739

Reserves & Surplus

1519.643

2649.738

2412.115

Share Application money pending allotment

0.000

45.739

0.000

Net worth

2319.643

3495.477

3257.854

 

 

 

 

long-term borrowings

3562.681

3355.522

3415.149

Short term borrowings

1456.278

1657.343

1600.558

Current Maturities of Long Term Debt

856.910

990.430

513.522

Total borrowings

5875.869

6003.295

5529.229

Debt/Equity ratio

2.533

1.717

1.697

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

9180.545

10847.912

12522.565

 

 

18.162

15.438

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

9180.545

10847.912

12522.565

Profit

141.855

300.454

979.422

 

1.55%

2.77%

7.82%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

No

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

Yes

33

Market information

---

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

LITIGATION DETAILS

 

 

 

HIGH COURT OF GUJARAT

 

SPECIAL CIVIL APPLICATION No. 419 of 2013

Status : PENDING

( Converted from : ST/17405/2012 )

CCIN No : 001021201300419

 

 

Next Listing Date:

18/06/2015

Coram

·         HONOURABLE MR.JUSTICE A.J.DESAI

Not Before :

·         HONOURABLE MR.JUSTICE R.M.CHHAYA

 

S.NO.

Name of the Petitioner

Advocate On Record

1

RAPTAKOS BRETT AND COMPANY LIMITED

MR DAKSHESH MEHTA for: Petitioner(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

 

S.NO.

Name of the Respondant

Advocate On Record

1
2
3

INTELLECTUAL PROPERTY APPELLATE BOARD
CADILA PHARMACEUTICALS LTD
ASSISTANT REGISTRAR OF TRADE MARKS

NOTICE UNSERVED for :Respondent(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1
MR YJ TRIVEDI for :Respondent(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 2
MR IH SYED for :Respondent(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 3

 

 

Presented On

: 29/12/2012

Registered On

: 15/01/2013

Bench Category

: SINGLE BENCH

District

: AHMEDABAD

Case Originated From

: THROUGH HIS/HER/THEIR ADVOCATE

Listed

: 34 times

StageName

: FOR FINAL HEARING

 

 

Office Objection

Filing Stage
Filing Stage
Filing Stage
Filing Stage
Filing Stage

·         WHETHER INDEX-CUM-CHRONOLOGY OF DOCUMNETS AND EVENTS FILED ?

·         WHETHER PROPER & FULL COURT FEE IS PAID ?

·         WHETHER PAGING IS DONE ?

·         WHETHER COPIES ARE LEGIBLE AND WHETHER TYPED COPIES OF HAND WRITTEN ANNEXURES FILED ?

·         WHETHER COPIES ARE TRUE COPIES SO SIGNED BY ADVOCATE ?

 

Classification

·         SJ - NON-SERVICE - TRADE MARKS ACT, 1999

Act

·         TRADE UNIONS ACT, 1926

 

 

Office Details

 

S. No.

Filing Date

Document Name

Advocate Name

Court Fee on Document

Document Details

1

29/12/2012

VAKALATNAMA

MR DAKSHESH MEHTA ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

5

MR DAKSHESH MEHTA:1

2

29/12/2012

MEMO OF PETITION/APPEAL/SUIT

MR DAKSHESH MEHTA ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

50

MR DAKSHESH MEHTA:1

3

15/01/2013

VAKALATNAMA

MR YJ TRIVEDI ADVOCATE
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 2

4

MR YJ TRIVEDI:2

4

15/01/2013

VAKALATNAMA

MR DAKSHESH MEHTA ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

-

MR DAKSHESH MEHTA:1

5

15/01/2013

DOCUMENT

NOTICE SERVED 
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 3

-

NOTICE SERVED:3

6

15/01/2013

DOCUMENT

NOTICE UNSERVED 
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

-

NOTICE UNSERVED:1

7

14/02/2013

MEMO OF PETITION/APPEAL/SUIT

MR DAKSHESH MEHTA ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

50

MR DAKSHESH MEHTA:1

8

04/04/2013

VAKALATNAMA

MR YJ TRIVEDI ADVOCATE
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 2

5

MR YJ TRIVEDI:2

9

13/06/2013

APPEARANCE NOTE

MR HRIDAY BUCH ADVOCATE
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 3

0

MR HRIDAY BUCH(2372), for R:3

10

14/06/2013

AFFIDAVIT IN REPLY

MR YJ TRIVEDI ADVOCATE
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 2

0

MR YJ TRIVEDI(948) for R:2

11

16/07/2013

AFFIDAVIT IN RE-JOINDER

MR DAKSHESH MEHTA ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

0

MR DAKSHESH MEHTA(2430) for P:1

12

10/12/2013

APPEARANCE NOTE

MR IH SYED ADVOCATE
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 3

0

MR IH SYED(2321) for R:3

 

 

Court Proceedings

 

S. No.

Notified Date

CourtCode

Board Sr. No.

Stage

Action

Coram

1

15/01/2013

1

-

OFFICE OBJECTION (FILING STAGE)

NEXT DATE

·         ADDITIONAL REGISTRAR ( JUDICIAL)

2

17/01/2013

1

43

OFFICE OBJECTION (FILING STAGE)

NEXT DATE

·         HONOURABLE MR.JUSTICE Z.K.SAIYED

3

01/03/2013

1

3

OFFICE OBJECTION REMOVED

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

4

08/03/2013

1

6

BOARD NO. I (NOTICE & ADJOURNED MATTERS)

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

5

22/03/2013

1

36

FOR REGULAR ADMISSION

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

6

05/04/2013

1

21

BOARD NO. I (NOTICE & ADJOURNED MATTERS)

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

7

26/04/2013

1

74

BOARD NO. I (NOTICE & ADJOURNED MATTERS)

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

8

14/06/2013

1

55

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

9

05/07/2013

1

92

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

10

10/07/2013

1

37

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

11

17/07/2013

1

43

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

12

31/07/2013

1

41

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

13

12/08/2013

1

51

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

14

14/08/2013

1

29

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

15

02/09/2013

1

40

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

16

16/09/2013

8

45

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

17

08/10/2013

8

54

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE MR.JUSTICE ANANT S. DAVE

18

10/12/2013

8

45

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE MR.JUSTICE ANANT S. DAVE

19

07/01/2014

18

23

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE MR.JUSTICE ANANT S. DAVE 

·         HONOURABLE MR.JUSTICE A.J.DESAI

20

30/01/2014

18

23

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE MR.JUSTICE A.J.DESAI

21

12/03/2014

15

48

NOTICE & ADJOURNED MATTERS

FIXED RULE / ADMIT

·         HONOURABLE MR.JUSTICE A.J.DESAI

22

17/06/2014

17

46

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE R.M.CHHAYA 

·         HONOURABLE MR.JUSTICE C.L. SONI

23

30/06/2014

16

52

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE C.L. SONI

24

10/07/2014

16

21

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE C.L. SONI

25

08/08/2014

16

12

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE C.L. SONI

26

09/09/2014

15

43

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE G.B.SHAH 

·         HONOURABLE MR.JUSTICE C.L. SONI

27

08/10/2014

15

45

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE G.B.SHAH

28

14/11/2014

19

119

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE PARESH UPADHYAY

29

22/12/2014

19

201

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE PARESH UPADHYAY

30

09/02/2015

20

182

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE PARESH UPADHYAY

31

23/03/2015

19

143

FOR FINAL HEARING

NEXT DATE

·         HONOURABLE MR.JUSTICE A.J.DESAI 

·         HONOURABLE MR.JUSTICE PARESH UPADHYAY

32

18/06/2015

19

-

FOR FINAL HEARING

·         HONOURABLE MR.JUSTICE A.J.DESAI

 

 

Available Orders

 

 

S. No.

Case Details

Judge Name

Order Date

CAV

Judgement

Questions

Transferred

1

SPECIAL CIVIL APPLICATION/419/2013

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

08/03/2013

N

ORDER

-

Y

2

SPECIAL CIVIL APPLICATION/419/2013

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

22/03/2013

N

ORDER

-

Y

3

SPECIAL CIVIL APPLICATION/419/2013

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

14/06/2013

N

ORDER

-

Y

4

SPECIAL CIVIL APPLICATION/419/2013

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

16/09/2013

N

ORDER

-

Y

5

SPECIAL CIVIL APPLICATION/419/2013

·         HONOURABLE MR.JUSTICE A.J.DESAI

12/03/2014

N

ORDER

-

Y

 

 

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

Long term borrowing

 

 

Deposits from others

378.077

515.991

Other Loans and Advances

331.029

349.860

 

 

 

Total

709.106

865.851

 

Note : 

 

Optionally Convertible Cumulative Unsecured Bonds (OCCUB) :

 

[a] OCCUB (Series 3) of Rs.150.000 Million carries interest rate @11.50% and is due for redemption on 31st March, 2018.

 

[b] OCCUB (Series 2) of Rs.150.000 Million carries interest rate @11.50% and is due for redemption on 31st March, 2017.

 

Unsecured loan from Dept. of Science and Technology carries interest of 2% to 3% and repayble in 2-15 years period.

 

There are no defaults in repayment of loan and interest thereon as on March 31, 2014 for all the loans under this head.

 

 

REVIEW OF OPERATIONS

 

During the year, Cadila Pharmaceuticals Limited has continued its momentum and achieved the total revenue of Rs.13056.400 Million which shows growth of 15% over the previous year. The other income during the year grown by 76% to Rs.211.800 Million (previous year: Rs.120.000 Million). The efforts made by the Company during the year to tighten the working capital and borrowings have resulted into reduction in finance cost by 14%.

 

For the first time, the company achieved the profit before tax of Rs.1003.6 Million which was grown by 189% as compared to previous year, i.e. Rs.346.700 Million.

 

During the year, the export of API and Formulations by the Company was also grown by 23% to Rs.4670.000 Million. Total export during the year contributes 36% of total sales of the Company.

 

The Company is committed to introduce new products / molecules with its R&D efforts in the coming years and achieve substantial growth in sales as well as profitability.

 

 

NEW PRODUCTS, INNOVATIONS, ALLIANCES

 

At Cadila Pharmaceuticals, there is a sharp focus on Research and Development. Naturally, Innovation is at the centre of all of activities. A slew of innovative products down the years bear testimony to this. The company believes in forging Public-Private partnerships for developing diagnostic, preventive and curative pharmaceutical and diagnostic products. Many innovations have resulted from such partnerships.

 

During the year, Cadila Pharmaceuticals offered to the world, Mycidac-C, the first in the world innovative and affordable product for the patients suffering from Non Small Cell Lung Cancer (NSCLC), one of the main types of Lung Cancers.

 

The company was also the first in the world to introduce Rabeprazole in IV form. With Biotech, Vaccine adjuvants, Stem cells banking as few other thrust areas, Cadila Pharmaceuticals now covers the entire spectrum of human healthcare. In fact, the company has chalked out robust plan to add one/two biotech products every year.

 

Cadila Pharmaceuticals has the highest number of commercialized biological products to its credit as compared to any other pharmaceuticals company in the state of Gujarat, India.

 

In 2013, Cadila Pharmaceuticals entered into a strategic collaboration with Pergamum AB, Sweden, to develop a novel treatment of infections with a unique targeting mechanism clearly distinguished from classical antibiotics. Cadila Pharmaceuticals and UK-based antibiotics discovery major, Helperby Therapeutics signed a joint agreement on Antibiotic Drug Resistance Research and Development, a major breakthrough in the fight against antibiotic resistance with the discovery of patented resistance breaker compounds.

 

In 2014, NovaSAID initiated a partnership with Cadila Pharmaceuticals to develop innovative treatments in inflammation and pain management.

 

SCHEME OF AMALGAMATION

 

1.1 A Scheme of Amalgamation (the Scheme) under Section 391 to 394 of Companies Act,1956, for amalgamation of IRM Properties Private Limited ("IPPL" or "Transferor Company") into Cadila Pharmaceuticals Limited ("the Company"), was sanctioned by the Honble High Court of Gujarat on 20th November,2013. The Scheme, which became operative from effective date i.e. 27th February, 2014 i.e. date of filling the certified copies of the Orders of the Honble High Court of Gujarat, with the Registrar of Companies, Ahmedabad, Gujarat, was effective from the appointed date i.e. 25th March, 2013.

 

1.2 The Transferor Company was engaged in property business.

 

1.3 Pursaunt to the Scheme, with effect from the Appointed date, the whole of the undertaking and assets, properties, debts, liabilities, duties and obligations of the Transferor Company have, under the provisions of Sections 391-394 and all applicable provisions, if any of the Act, without any further act or deed , stand transferred to and vested in and/or deemed to be transferred to and vested to Company, so as to become the business, assets and properties of Company as a part of and consequent upon the Scheme. The undertaking of Transferor have includes all the Transferor Company’s Reserves, movable and immovable properties, assets, including lease-hold rights, tenancy rights, industrial and other licenses, registrations, permits, authorisations, quota rights, trade marks, patents and other industrial and intellectual properties, import quotas, electrical connections, telephones, telex, facsimile and other communication facilities and equipments, rights and benefits of all agreements, pending applications and all other interests, rights and powers of every kind, nature and description whatsoever, privileges, liberties, easements, advantages, benefits and approvals of the Transferor Company.

 

1.4 Pursuant to the Scheme, the authorised share capital of the Company consisting of Rs.800.000 Million comprising of 800.000 Million (Eight Crore) equity shares of Rs.10/-each have automatically stand increased by the authorised share capital of Transferor Company amounting to Rs.460.000 Million.

 

1.5 In consideration for the amalgamation, the equity shareholders of IPPL, holding fully paid-up equity shares in IPPL on the

effective date, 1 (one) fully paid up 0.01% Redeemable Non-Cumulative Preference Share of Rs.10/-each of the Company had been issued and

allotted for every 10(Ten) equity share of Rs 1 held in IPPL.

 

1.6 All the employees of IPPL in service as on effective date have become employee of the Company without any break or interruption in their service on same terms and conditions on which they were engaged as on the effective date. Company further agrees that for the purpose of payment of any retirement benefit/compensation, such immediate uninterrupted past services with the Transferor Company, as the case may be, shall also be taken into account. The Company undertakes to continue to abide by the terms of agreement /settlement entered into by the Transferor Company with employees union / employee or associations as the case may be.

 

1.7 The amalgamation had been accounted as per "Amalgamation in the nature of Purchase" as prescribed in Accounting Standard

 

14 - "Accounting for Amalgamation". Accordingly, the Company had recorded all the assets and liablities appearing in the books of account of IPPL and transferred to and vested in the Company at their respective fair values as determined by board of directors of the Company as on the effective date. The fair value of the land and building was as certified by the independent valuer and for other assets and liabilities was based on managements assessment of its recoverability and liability for payment. The difference between the excess of the Net Assets Value of IPPL transferred to and recorded by the Company and face value of Preference shares allotted as per 1.5 above, have been credited to Securities Premium account of the Company. "Net Assets Value" is the fair value of assets less fair value of liabilities of the Transferor Company transferred to the Company.

 

1.8 Pursuant to the Scheme, with effect from Appointed Date and for any of the financial years ending on or after the Appointed Date, if considered appropriate by the Board of Directors of the Company, any or all of the Extraordinary and Exceptional items may be adjusted against the General Reserves of the Company. Extraordinary and / or Exceptional items means: (a) Impairment, amortization and / or write off / diminution in value of investments and other assets, both tangible and intangible including goodwill, if any, (b) Costs/ expenses / charge / losses on account of write down or transfer of assets or contingent liabilities or deferred tax liabilities which may be suffered by or be required to be accounted by CPL, pursuant to this Scheme or otherwise in the course of its business or in carrying out such restructuring of the operations of CPL as the Board of Directors of CPL consider necessary or proper, (c) Any other costs/ expenses / charge / losses / liabilities which in the opinion of the Board of Directors are extraordinary and exceptional.

 

In pursuant to Scheme, the Board of Directors of the Company has approved for write off of Rs 936.256 Million comprises of debtors Rs 75.901 Million investment Rs 719.616 Million loans and advances Rs 38.104 Million Intangible Assets Rs. 79.850 Million Stock Rs.22.785 Million (Previous year Rs.256.559 Million, comprises of debtors Rs.247.977 Million and loans and advances of Rs.8.582 Million) in Board meeting dated 8th July 2014 (Previous year Board meeting dated 20th November,2013) and to transfer the similar amount from the balance of General Reserve of Company to Profit and Loss Account.

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10490013

25/03/2014

350,000,000.00

Export-Import Bank Of India

Export-Import Bank Of India, Centre One Building, Floor 21, Wtc Complex, Mumbai, Maharashtra - 400005, India

C03360146

2

10481788

10/02/2014

1,250,000,000.00

Bank Of Baroda

Corporate Financial Services Branch, 1st Floor,, 
Bob Towers, Opp. Law Garden, Ellisbridge, Ahmedabad, Gujarat - 380009, India

B98178411

3

10466339

29/11/2013

500,000,000.00

Union Bank Of India

Ifb, C. U. Shah Chambers, Ashram Road, Ahmedabad, Gujarat - 380014, India

B92018449

4

10384789

17/10/2012

500,000,000.00

Bank Of Baroda

Corporate Financial Services Branch, Bank Of Baroda Towers, Ellisbridge, Ahmedabad, Gujarat - 380006, India

B61496022

5

10349308

09/04/2012

420,000,000.00

Export-Import Bank Of India

Centre One Building, Floor 21, World Trade Centre Complex, Cuffe Parade, Mumbai, Maharashtra - 400005, India

B37458825

6

10329665

20/12/2011

650,000,000.00

Bank Of Baroda

Corporate Financial Services Branch, Bank Of Baroda Towers, Ellisbridge, Ahmedabad, Gujarat - 380006, India

B29858016

7

10284330

21/08/2013 *

500,000,000.00

Indian Overseas Bank

401, 403 Sigma Legacy, Nr. Polytechnic Cross Road, Iirm Road, Ahmedabad, Gujarat - 380015, India

B84319458

8

10260601

21/12/2010

480,000,000.00

Bank Of Baroda

Corporate Financial Services Branch, Bank Of Baroda Towers, Ellisbridge, Ahmedabad, Gujarat - 380006, India

B03237732

9

10157250

08/04/2009

2,550,000.00

Department Of Biotechnology

Block 2, Cgo Complex, Lodhi Road, New Delhi, Delhi - 110003, India

A61567855

10

10090235

31/01/2008

4,320,000.00

Hdfc Bank Limited

Hdfc Bank House, Senapati Bapat Marg, Lower Parel W, Mumbai, Maharashtra - 400013, India

A33032723

11

10084310

15/03/2010 *

104,000,000.00

Canara Bank

Opp Advance Cinema, Bhadra, Ahmedabad, Gujarat - 380001, India

A82495987

12

90103410

28/11/2013 *

2,500,000,000.00

Bank Of Baroda

Corporate Financial Services Branch, 1st Floor, 
Bob Towers, Opp. Law Garden, Ellisbridge, Ahmedabad, Gujarat - 380009, India

B92365683

13

90103321

06/10/2003

40,000,000.00

Canara Bank

Bhadra Branch, Ahmedabad, Gujarat - 380001, India

-

14

90103308

18/04/2003

30,000,000.00

Bank Of Baroda

Ashram Road Branch, Ahmedabad, Gujarat - 380009, India

-

15

90103304

28/03/2003

225,000,000.00

Bank Of Baroda

Ashram Road Branch, Ahmedabad, Gujarat, India

-

16

90103292

23/10/2002

50,000,000.00

Bank Of Baroda

Ashram Road Branch, Ahmedabad, Gujarat - 380009, India

-

17

90103281

11/02/2014 *

6,800,000,000.00

Bank Of Baroda

Corporate Financial Services Branch, Bob Towers, Opp. Lawgarden, Ellisbridge, Ahmedabad, Gujarat - 380009, India

B98178619

18

90103277

12/04/2002

20,000,000.00

Canara Bank

Bhadra Branch, Ahmedabad, Gujarat - 380001, India

-

19

90103273

22/03/2002

15,000,000.00

Bank Of Baroda

Ashram Road Branch, Ahmedabad, Gujarat, India

-

20

90103269

21/01/2002

3,100,000.00

Union Bank Of India

Industrial Finance Branch, Ashram Road Branch, Ahmedabad, Gujarat - 380014, India

-

21

90103245

28/05/2001

5,000,000.00

Corporation Bank

Navrangpura Branch, Ahmedabad, Gujarat, India

-

22

90103234

27/03/2002 *

100,000,000.00

Exprot- Import Bank Of India

Centre 1; Floor21, World Trade Centre; Cuffe Parade, Mumbai, Maharashtra - 400005, India

-

23

90103226

08/01/2001

100,000,000.00

Export - Import Bank Of India

Centre One; World Trade Centre, Cuffe Parade, Mumbai, Maharashtra - 400005, India

-

24

90103221

01/12/2000

30,000,000.00

Indian Bank

Bhadra Mission Road, Ahmedabad, Gujarat - 380001, 
India

-

25

90103219

29/11/2000

9,000,000.00

Corporation Bank

Nvrangpura Branch, Ahmedabad, Gujarat, India

-

26

90103209

29/09/2000

60,000,000.00

Bank Of Baroda

Ashram Road, Ahmedabad, Gujarat - 380009, India

-

27

90103170

18/01/2001 *

100,000,000.00

Export - Import Bank Of India

Centre One; World Trade Centre, Cuffe Parade, Mumbai, Maharashtra - 400005, India

-

28

90103160

18/01/2001 *

450,000,000.00

ICICI Limited

ICICI Towers, Bandra Kurla Complex; Bandra, Mumbai, Maharashtra - 400051, India

-

29

90103142

12/09/2005 *

780,000,000.00

Bank Of Baroda

Ashram Road Branch, Ahmedabad, Gujarat - 380009, India

-

30

90103141

28/11/2013 *

2,500,000,000.00

Bank Of Baroda

Corporate Financial Services Branch, 1st Floor, BOB Towers, Opp. Law Garden, Ellisbridge, Ahmedabad, Gujarat - 380009, India

B92363951

31

90103099

09/11/1995 *

11,200,000.00

Bank Of Baroda

Ashram Road Branch, Ahmedabad, Gujarat - 380009, India

-

32

90314778

16/07/1994 *

80,000,000.00

Bank Of Baroda

Ashram Road, Ahmedabad, Gujarat, India

-

33

90314702

13/02/1991

25,000,000.00

Bank Of Baroda

Ashram Road, Ahmedabad, Gujarat, India

-

34

90314186

06/10/1988

3,000,000.00

Bank Of Baroda

Ashram Road, Ahmedabad, Gujarat, India

-

35

90378926

16/07/1988

3,000,000.00

Orissa State Financial Corporation

Omp Square, Cuttack, Orissa, India

-

36

90378866

23/04/1991 *

36,000,000.00

United Bank Of India

Cuttack, Cuttack, Orissa, India

-

37

90313496

14/05/1992 *

200,000.00

Bank Of Baroda

Ashram Road, Ahmedabad, Gujarat, India

-

38

90378785

11/02/1985 *

1,800,000.00

Industrial Promotion And Investment Corporation Of 
Orrissa L

Janpath, Bhubneshwar, Orissa, India

-

*Date of modification Charges

 

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Office Building

·         Plant and equipment

·         Factory Equipment’s

·         Furniture and fixtures

·         Vehicles

·         Motor Vehicles

·         Office Equipment

·         Other Equipment’s

·         Livestock

·         Computer software

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 
Unit

Indian Rupees

US Dollar

1

Rs.63.76

UK Pound

1

Rs.97.79

Euro

1

Rs.69.91

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

SNT

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

7

--CREDIT LINES

1~10

5

--MARGINS

-5~5

----

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.